Valneva SE
(NASDAQ: VALN)
|
5:30 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $7.19 | Change: -0.06 | %Change: -0.79% | Volume: 2,623 |
Open: | $ 7.29 | Volume: | 2,623 | |
---|---|---|---|---|
High: | $ 7.34 | Yield(%) | 0.00 | |
Low: | $ 7.19 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 504.43M | |
EPS ($) | -0.38 | Shares Out: | 69.58M |
% Price Change (last 4 weeks): | -17.93 |
---|---|
% Price Change (last 13 weeks): | -6.09 |
% Price Change (last 26 weeks): | -29.20 |
% Price Change (last 52 weeks): | -51.57 |
% Price Change (year to date): | -30.08 |
Return on Equity (%): | -58.29 |
---|---|
Return on Assets (%): | -18.37 |
Return on Invested Capital (%): | -28.70 |
Gross Profit Margin (%): | 31.58 |
---|---|
Net Profit Margin (%): | -65.99 |
Operating Profit Margin (%): | -67.71 |
|
|
50-day Moving Average: | $7.92 |
---|---|
200-day Moving Average: | $9.31 |
Avg. Daily Vol. (last 50 days): | 13,092 |
Avg. Daily Vol. (last 200 days): | 9,264 |
52-wk high: | $16.49 |
52-wk low: | $6.58 |
Bid: | $7.18 |
Ask: | $7.32 |
Valneva SE is a specialty vaccine company, which focuses on the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases. It operates through the following segments: Commercialized Products, COVID, Vaccine Candidates, and Technologies and Services. The Commercialized Products segment markets vaccines, currently IXIARO and DUKORAL vaccines, as well as third-party products. The COVID segment develops, manufactures, and distribute related to COVID-19 vaccine candidate, VLA2001. The Vaccine Candidates segment focuses on proprietary research and development programs aiming to generate new approvable products to generate future cash flows from product sales or from commercialization through partnering with pharmaceutical companies. The Technologies and Services segment offers services and inventions at a commercialization stage. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.
|
Valneva SE
Campus Bio-Ouest 6, rue Alain Bombard Saint-Herblain GE 44800 Phone: 33.2.28.07.37.10 Fax: n/a http://www.valneva.com |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 2.04 |
Cash Flow ($): | -1.31 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 4.32 |
Price/Book (x): | 5.08 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 1.37 |
---|---|
Current Ratio (x): | 1.65 |
LT Debt/Equity (x): | 126.21 |
Total Debt/Equity (x): | 162.82 |